Preventing and controlling influenza with available interventions

New England Journal of Medicine

Volumn 370, Issue 9, 2014, Pages 789-791

  Uyeki, Timothy M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; CLINICAL FEATURE; CRITICAL ILLNESS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EARLY INTERVENTION; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; INFLUENZA VIRUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; SHORT SURVEY; SYMPTOM ASSESSMENT; TREATMENT DURATION; VIRUS TRANSMISSION;

AGE FACTORS; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84896689847     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1400034     Document Type: Article

References (5)

1. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013;62(RR-07):1-43.
2. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19. [Erratum, N Engl J Med 2010;362:2039.]
3. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
4. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013;207:553-63.
5. Hui DS, Lee N, Chan PK. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res 2013;98:410-6.